Lipid levels and their genetic regulation in patients with familial hypercholesterolemia and familial defective apolipoprotein B-100: the MEDPED Slovakia Project.
Atheroscler Suppl
; 4(3): 3-5, 2003 Nov.
Article
en En
| MEDLINE
| ID: mdl-14615272
ABSTRACT
We examined, from a cohort of 165 families, 529 individuals for familial hypercholesterolemia (FH). Utilising clinical criteria for diagnosis, we identified 122 patients (n=41 families) as having FH. With PCR testing, 31 individuals (n=12 families) were found to have familial defective Apo B-100 (FDB). From the cohort, 102 normolipidemic (NL) individuals served as a control group. Patients with FH had the highest levels of total cholesterol (TC), LDL-cholesterol (LDL-C) and apolipoprotein B (Apo B), followed by FDB patients and the normolipidemic relatives had the lowest levels (P<0.0001 for all parameters). We did not find any effect of Apo E genotypes on lipid levels in the NL or FH group. Therefore, other genetic and/or environmental factors may be responsible for the diversity in the clinical expression in these populations.
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Apolipoproteínas B
/
Hiperlipoproteinemia Tipo II
/
Lípidos
Tipo de estudio:
Prognostic_studies
Límite:
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Atheroscler Suppl
Asunto de la revista:
ANGIOLOGIA
Año:
2003
Tipo del documento:
Article